Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs WALTHAM, Mass., Feb. 17, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently... Read more

Establishment of HORIBA Institute for Particle Analysis in AIST TSUKUBA

02/16/2021 |   Press Release Committed to Implementing a System That Enables the World’s Highest Level of Particle Analysis Key points Development of analysis technology for fine airborne particles in order to satisfy more stringent environmental regulatory requirement Development of an analysis and evaluation system for leading-edge nanomaterials that contribute to strengthening of industrial competitiveness Realization of synergistic... Read more

SPT Labtech acquires BioMicroLab

Deal strategically expands SPT Labtech’s offering in sample management for life sciences  To download this image, please click here. Cambridge, UK – 16 February 2021 – SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, announces the acquisition of BioMicroLab, a robotics automation provider for life science laboratories. Headquartered... Read more

PerkinElmer Launches First Cell Painting Kit

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the first cell painting kit as part of its new portfolio of PhenoVue™ cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside the Company’s microplates, automation, software and industry-leading... Read more

PerkinElmer to Present at Cowen Health Care Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 16, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 41st Annual Cowen Health Care Conference on Monday, March 1, 2021 from 12:20 p.m. to 12:50 p.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer,... Read more

FDA Grants Emergency Use Authorization for New COVID-19, Flu A, Flu B Combo Kit

One multiplex real-time PCR diagnostic kit can simultaneously detect and differentiate SARS-CoV-2, influenza A and influenza B CARLSBAD, Calif., Feb. 16, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit from Thermo Fisher Scientific, the company announced... Read more

Thermo Scientific Helios 5 PXL PFIB Wafer DualBeam Enables Inline Metrology of Advanced 3D Structures

Thermo Scientific Helios 5 PXL PFIB Wafer DualBeam Enables Inline Metrology of Advanced 3D Structures Fully automated system decreases time-to-data for through-stack metrology from days to hours HILLSBORO, Ore., Feb. 16, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today launched the Thermo Scientific Helios 5 PXL PFIB Wafer DualBeam. The system,... Read more

Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results

Q4 2020 revenues up 4.6% year-over-year; organic revenue declines 0.4% Q4 2020 GAAP EPS of $0.45; non-GAAP EPS of $0.58 Expanded Project Accelerate 2.0 in proteomics, spatial biology and molecular diagnostics Strong revenue growth, Non-GAAP margin expansion and EPS growth expected in FY 2021 BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced financial results... Read more

New phase III data show Roche’s faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in two leading causes of vision loss, potentially reducing treatment burden for patients

Across four studies in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), approximately half of people receiving faricimab could be treated every four months in the first year Approximately three-quarters of people receiving faricimab could be treated every three months or longer in the first year Faricimab showed rapid and consistent improvements in... Read more

Thermo Fisher Scientific Invests $25 Million to Support Black Communities and Businesses in the U.S.

Thermo Fisher Scientific Invests $25 Million to Support Black Communities and Businesses in the U.S. WALTHAM, Mass., Feb. 11, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has committed to investing up to $25 million in minority-serving financial institutions. “Unequal access to capital is hurting... Read more